CHINA BIOLOGIC PRODUCTS, INC. INDEPENDENT DIRECTOR AGREEMENTChina Biologic Products • March 23rd, 2012 • China Biologic Products, Inc. • Biological products, (no disgnostic substances) • New York
THIS AGREEMENT (The “Agreement”) is made as of the 19th day of March 2012 and is by and between China Biologic Products, Inc., a Delaware corporation (hereinafter referred to as the “Company”), and Yungang Lu (hereinafter referred to as the “Director”).
CHINA BIOLOGIC PRODUCTS, INC. DIRECTOR AGREEMENTChina Biologic Products • March 4th, 2015 • China Biologic Products, Inc. • Biological products, (no disgnostic substances) • New York
THIS AGREEMENT (The “Agreement”) is made on March 4, 2015 and is by and between China Biologic Products, Inc., a Delaware corporation (hereinafter referred to as the “Company”), and Mr. Min Fang (hereinafter referred to as the “Director”).
CHINA BIOLOGIC PRODUCTS, INC. INDEPENDENT DIRECTOR AGREEMENTChina Biologic Products • November 6th, 2014 • China Biologic Products, Inc. • Biological products, (no disgnostic substances) • New York
THIS AGREEMENT (The “Agreement”) is made as of the 3th day of November 2014 and is by and between China Biologic Products, Inc., a Delaware corporation (hereinafter referred to as the “Company”), and Mr. Joseph Chow (hereinafter referred to as the “Director”).
CHINA BIOLOGIC PRODUCTS, INC. 3,500,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENTChina Biologic Products • March 4th, 2016 • China Biologic Products, Inc. • Biological products, (no disgnostic substances) • New York
Certain stockholders (the “Selling Stockholders”) of China Biologic Products, Inc., a Delaware corporation (the “Company”) named in Schedule II hereto severally and not jointly propose to sell to the underwriter named in Schedule I hereto (the “Underwriter”), an aggregate of 3,500,000 shares of common stock of the Company, par value $0.0001 per share (the “Shares”). The shares of common stock of the Company, par value $0.0001 per share, to be outstanding after giving effect to the sales contemplated hereby are hereinafter referred to as the “Common Stock.”
CHINA BIOLOGIC PRODUCTS, INC. 1,550,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENTChina Biologic Products • June 27th, 2014 • China Biologic Products, Inc. • Biological products, (no disgnostic substances) • New York
CHINA BIOLOGIC PRODUCTS, INC. INDEPENDENT DIRECTOR AGREEMENTChina Biologic Products • July 30th, 2008 • China Biologic Products, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS AGREEMENT (The "Agreement") is made as of the ____ day of ____ and is by and between China Biologic Products, Inc., a Delaware corporation (hereinafter referred to as the "Company"), and _____ (hereinafter referred to as the "Director").
